Company News - VC and PE investment business - Medical and health professional investment - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 01 - 16

Efung Capital's Portfolio Companies Make Collective Appearance at JPM

On January 12, 2026 local time, the 44th Annual J.P. Morgan Healthcare Conference kicked off in San Francisco, USA. Efung Capital's portfolio companies – Ascentage Pharma, HighLight Pharma, Andao Pharma, NewCo Scientific, and MedLinc – made a collective appearance at JPM, with Ascentage Pharma delivering a presentation at the main forum.Efung Capital CEO Ben attended the conference, marking the firm's fourth participation in JPM. He engaged with global biotech leaders and seasoned investors to explore industry trends and partnership opportunities, while showcasing the "potential a...

浏览次数：1

查看详情>>

发布时间: 2026 - 01 - 14

Efung Capital Honored on Rongzhong 2025 Annual China Equity Investment Ranking | Fenix Glory

On January 14, 2026, the Rongzhong 2025 Annual China Equity Investment Ranking was officially unveiled. Fenix Capital was named to the "Rongzhong 2025 Annual Top 100 Chinese Venture Capital Institutions," and Efung Capital CEO Zhu Pai was recognized as a "Rongzhong 2025 Outstanding Chinese Investor."Leveraging its proprietary database, BridgeData, combined with questionnaire collection, research interviews, and comprehensive data validation, Rongzhong Research conducted an overall assessment in consideration of market and industry development trends.Looking ahead, Efung Cap...

浏览次数：1

查看详情>>

发布时间: 2025 - 12 - 31

Anchoring Innovation, Winning the Future: Efung Capital's 2025 Journey

2025: China's Pharmaceutical Industry Reaches a Global Tipping PointThe Economist recently noted that the "source" of global innovation is shifting, and global life sciences are entering a clear "China Moment." China's standing in the global life sciences ecosystem is rapidly rising, and global capital is repricing China. This may not only mark the takeoff point for China's biopharmaceutical industry but also propel China from the later stages of the industrial civilization toward the frontier of the life sciences civilization.In this historic process, Efung Cap...

浏览次数：2

查看详情>>

发布时间: 2025 - 12 - 30

Monthly Health Read | December 2025

On December 26, the National Venture Capital Guidance Fund was officially launched in Beijing. The three regional funds—the Beijing-Tianjin-Hebei Venture Capital Guidance Fund, the Yangtze River Delta Venture Capital Guidance Fund, and the Greater Bay Area Venture Capital Guidance Fund—formally signed agreements with the first batch of 49 sub-funds and 27 project representatives. As one of the first batch of signatories, Efung Capital signed the agreement in Beijing, safeguarding the life and health industry.In the same month, Efung's portfolio companies demonstrated vibrant momentum, achi...

浏览次数：2

查看详情>>